Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X:
“Pan-RAS inhibitor Daraxonrasib in 2L of pancreatic cancer
ORR KRAS G12X: 36%, RAS mt: 27%
For comparison ORR with nal-IRI-FU/LV in NAPOLI-1: 7.7%.”
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X:
“Pan-RAS inhibitor Daraxonrasib in 2L of pancreatic cancer
ORR KRAS G12X: 36%, RAS mt: 27%
For comparison ORR with nal-IRI-FU/LV in NAPOLI-1: 7.7%.”